These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27314459)

  • 1. Erythropoietin to reduce allogeneic red blood cell transfusion in patients undergoing total hip or knee arthroplasty.
    Voorn VM; van der Hout A; So-Osman C; Vliet Vlieland TP; Nelissen RG; van den Akker-van Marle ME; Dahan A; Marang-van de Mheen PJ; van Bodegom-Vos L
    Vox Sang; 2016 Oct; 111(3):219-225. PubMed ID: 27314459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell Salvage in Hip and Knee Arthroplasty: A Meta-Analysis of Randomized Controlled Trials.
    van Bodegom-Vos L; Voorn VM; So-Osman C; Vliet Vlieland TP; Dahan A; Koopman-van Gemert AW; Vehmeijer SB; Nelissen RG; Marang-van de Mheen PJ
    J Bone Joint Surg Am; 2015 Jun; 97(12):1012-21. PubMed ID: 26085536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient blood management in elective total hip- and knee-replacement surgery (Part 1): a randomized controlled trial on erythropoietin and blood salvage as transfusion alternatives using a restrictive transfusion policy in erythropoietin-eligible patients.
    So-Osman C; Nelissen RG; Koopman-van Gemert AW; Kluyver E; Pöll RG; Onstenk R; Van Hilten JA; Jansen-Werkhoven TM; van den Hout WB; Brand R; Brand A
    Anesthesiology; 2014 Apr; 120(4):839-51. PubMed ID: 24424070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness and safety of preoperative use of erythropoietin in patients scheduled for total hip or knee arthroplasty: A systematic review and meta-analysis of randomized controlled trials.
    Zhao Y; Jiang C; Peng H; Feng B; Li Y; Weng X
    Medicine (Baltimore); 2016 Jul; 95(27):e4122. PubMed ID: 27399121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analysis and systematic review evaluating the use of erythropoietin in total hip and knee arthroplasty.
    Li Y; Yin P; Lv H; Meng Y; Zhang L; Tang P
    Ther Clin Risk Manag; 2018; 14():1191-1204. PubMed ID: 30022832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of perioperative allogeneic and autologous blood transfusion on acute wound infection following total knee and total hip arthroplasty.
    Newman ET; Watters TS; Lewis JS; Jennings JM; Wellman SS; Attarian DE; Grant SA; Green CL; Vail TP; Bolognesi MP
    J Bone Joint Surg Am; 2014 Feb; 96(4):279-84. PubMed ID: 24553883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient blood management in elective total hip- and knee-replacement surgery (part 2): a randomized controlled trial on blood salvage as transfusion alternative using a restrictive transfusion policy in patients with a preoperative hemoglobin above 13 g/dl.
    So-Osman C; Nelissen RG; Koopman-van Gemert AW; Kluyver E; Pöll RG; Onstenk R; Van Hilten JA; Jansen-Werkhoven TM; van den Hout WB; Brand R; Brand A
    Anesthesiology; 2014 Apr; 120(4):852-60. PubMed ID: 24434302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic Blood Transfusion Is a Significant Risk Factor for Surgical-Site Infection Following Total Hip and Knee Arthroplasty: A Meta-Analysis.
    Kim JL; Park JH; Han SB; Cho IY; Jang KM
    J Arthroplasty; 2017 Jan; 32(1):320-325. PubMed ID: 27682006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of a de-implementation strategy to reduce low-value blood management techniques in primary hip and knee arthroplasty: a pragmatic cluster-randomized controlled trial.
    Voorn VMA; Marang-van de Mheen PJ; van der Hout A; Hofstede SN; So-Osman C; van den Akker-van Marle ME; Kaptein AA; Stijnen T; Koopman-van Gemert AWMM; Dahan A; Vliet Vlieland TPMM; Nelissen RGHH; van Bodegom-Vos L
    Implement Sci; 2017 May; 12(1):72. PubMed ID: 28558843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness and safety of tranexamic acid in total hip or knee arthroplasty: a meta-analysis of 2720 cases.
    Wei Z; Liu M
    Transfus Med; 2015 Jun; 25(3):151-62. PubMed ID: 26033447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion Thresholds for Major Orthopedic Surgery: A Systematic Review and Meta-analysis.
    Mitchell MD; Betesh JS; Ahn J; Hume EL; Mehta S; Umscheid CA
    J Arthroplasty; 2017 Dec; 32(12):3815-3821. PubMed ID: 28735803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red blood cell transfusions for elective hip and knee arthroplasty: opportunity to improve quality of care and documentation.
    Cook SS; Cangialose CB; Sieburg DM; Kieszak SM; Boudreau R; Hoffman LH; Elward KS; Ballard DJ
    Clin Perform Qual Health Care; 1999; 7(1):5-16. PubMed ID: 10351595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of postoperative autotransfusion in total joint arthroplasty reduces allogeneic blood requirements: a meta-analysis of randomized controlled trials.
    Ji W; Lin X; Zhang R; Tang P; Mo J; Teng X; Fan Q; Wang B; Fan S; Zhang J; Chen S; Huang K
    BMC Musculoskelet Disord; 2017 Sep; 18(1):378. PubMed ID: 28865444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative anaemia is associated with increased allogeneic pack red cell transfusion in revision hip and knee joint arthroplasty: a retrospective analysis of 5387 patients over a 10-year period at a single high volume centre.
    Kasivisvanathan R; Ramesh V; Rao Baikady R; Nadaraja S
    Transfus Med; 2016 Aug; 26(4):271-7. PubMed ID: 27241366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Preoperative Erythropoietin on Allogeneic Blood Transfusions in Surgical Patients: Results From a Systematic Review and Meta-analysis.
    Cho BC; Serini J; Zorrilla-Vaca A; Scott MJ; Gehrie EA; Frank SM; Grant MC
    Anesth Analg; 2019 May; 128(5):981-992. PubMed ID: 30649068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Michigan Experience with Safety and Effectiveness of Tranexamic Acid Use in Hip and Knee Arthroplasty.
    Hallstrom B; Singal B; Cowen ME; Roberts KC; Hughes RE
    J Bone Joint Surg Am; 2016 Oct; 98(19):1646-1655. PubMed ID: 27707851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative Allogeneic Red Blood-Cell Transfusion Associated with Surgical Site Infection After Total Hip and Knee Arthroplasty.
    Everhart JS; Sojka JH; Mayerson JL; Glassman AH; Scharschmidt TJ
    J Bone Joint Surg Am; 2018 Feb; 100(4):288-294. PubMed ID: 29462032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Most Effective Regimen of Tranexamic Acid for Reducing Bleeding and Transfusions in Primary Total Knee Arthroplasty: A Meta-Analysis of Randomized Controlled Trials.
    Dai WL; Zhou AG; Zhang H; Zhang J
    J Knee Surg; 2018 Aug; 31(7):654-663. PubMed ID: 28895645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of preoperative erythropoiesis-stimulating agents (ESAs) in patients who underwent knee or hip arthroplasty: a meta-analysis of randomized clinical trials.
    Alsaleh K; Alotaibi GS; Almodaimegh HS; Aleem AA; Kouroukis CT
    J Arthroplasty; 2013 Oct; 28(9):1463-72. PubMed ID: 23528548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human erythropoietin reduces allogeneic blood transfusion requirements in patients undergoing major orthopedic surgery.
    Tamir L; Fradin Z; Fridlander M; Ashkenazi U; Zeidman A; Cohen AM; Hendel D; Mittelman M
    Haematologia (Budap); 2000; 30(3):193-201. PubMed ID: 11128112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.